Preclinical and clinical studies on CAR-NK cell therapy: latest update from 2025 ASH Annual Meeting
Abstract Chimeric antigen receptor–engineered natural killer (CAR-NK) cells are emerging as an off-the-shelf immunotherapy for hematologic malignancies, supported by early clinical data and a favorable safety profile. Compared with CAR-T therapy, CAR-NK cells offer the potential for scalable allogen...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-05-01
|
| Col·lecció: | Experimental Hematology & Oncology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s40164-026-00780-6 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|